Dr. Stephen Byrn will be speaking at the 2nd Controlled & Modified Drug Release in Philadelphia, PA on May 13-14, 2015.

NEW YORK, NY, UNITED STATES OF AMERICA, April 10, 2015 /EINPresswire.com/ -- Curtis & Coulter, LLC announces that Dr. Stephen Byrn will be speaking at the 2nd Controlled & Modified Drug Release, May 13-14, 2015 at the Hilton Philadelphia at Penn’s Landing.

Dr. Stephen Byrn will join a panel of experts on Accelerating Time to Market Through Innovation in Formulation Design and Drug Delivery. The program will also feature a FDA Regulatory Update regarding Guidance on Pharmacokinetics and Clinical Evaluation of Sustained & Modified Release Dosage Forms.

Curtis & Coulter, LLC’s Controlled & Modified Drug Release Conference is the premier formulation and drug delivery event, attended last year by more than 75 drug delivery, formulation, scientist and academic professionals. Other conference sessions will include:

• New approaches in modified release / modeling & simulation in modified release
• Advances in topical and transdermal delivery
• Application of in-vivo and in-silico modeling
• Understanding and establishing the right conditions for IVIVC correlation
• Parenteral controlled & sustained release
• Creating next generation products: Evaluating innovations in oral drug formulation and delivery technologies
• Combining in-vivo animal models with physiologically-based PBPK modeling

More information about the conference can be found at http://curtiscoulter.com/DDSEIN

# # #

Curtis & Coulter, LLC is a leading provider of business information to the Pharmaceutical and Biotech Industries. For more information please email Edward Santelices edward@curtiscoulter.com or call 732.313.1879.

A limited number of press passes are available for this event.

Edward Santelices
Curtis & Coulter, LLC
732-313-1879
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.